STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Lyell Immunopharma, Inc.
LYEL
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Trailing Twelve Months (TTM) Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Per Share (TTM)
Revenue/Share
$0.00
Net Income/Share
$-17.83
Operating CF/Share
$-9.03
Free CF/Share
$-9.06
Cash/Share
$17.50
Book Value/Share
$18.02
Tangible Book/Share
$18.02
Equity/Share
$18.02
Interest Debt/Share
$2.42
CapEx/Share
$0.03
Dividend/Share
$0.00
Valuation
Market Cap
$526.21M
Enterprise Value
$446.92M
P/E Ratio
-1.39
P/S Ratio
12,834.46
P/OCF Ratio
-2.74
P/FCF Ratio
-3.18
P/B Ratio
1.37
P/TB Ratio
1.37
EV/Sales
10,900.55
EV/EBITDA
-2.35
Graham Valuation
Graham Number
--
Graham Net-Net
$13.18
Profitability
Earnings Yield
-71.97%
FCF Yield
-31.46%
ROE
-96.68%
ROIC
-91.18%
Return on Tangible Assets
-79.83%
Dividend
Dividend Yield
0.00%
Payout Ratio
0.00%
Capital Allocation
CapEx/OCF
-0.32%
CapEx/Revenue
1268.29%
CapEx/Depreciation
0.04
SBC/Revenue
59373.17%
SG&A/Revenue
119612.20%
R&D/Revenue
378400.00%
Liquidity & Solvency
Debt/Equity
0.13
Debt/Assets
0.11
Debt/Market Cap
0.08
Net Debt/EBITDA
0.42
Current Ratio
10.30
Interest Coverage
0.00x
Income Quality
0.51
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Capital Structure
Tangible Assets
$329.12M
Working Capital
$296.32M
Invested Capital
$352.96M
Intangibles/Assets
0.00%